← Leaderboards
Hua Linda Cai
University Of California Los Angeles
$18,515,897
Attributed
$23,866,785
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,866,785 · 9
By mechanism
R01$23,564,392 · 8
R21$302,393 · 1
Top collaborators
- Ayako Makino5 shared
- Joshua I Goldhaber4 shared
- David G Harrison4 shared
- Peipei Ping4 shared
- James N Weiss4 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Joshua I Goldhaber$15,262,660
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMediatingProductionInnovationNovel TherapeuticsBlood VesselsIn VivoProtein IsoformsPreventSignal TransductionEndothelial CellsKnockout MiceBaseAttenuatedEndotheliumNitric OxideReactive Oxygen SpeciesNadph OxidasePathway InteractionsResearch StudyAnimalsInsightRegulationHypertension
Grant awards (52)
Targeting NOX4-dependent mitochondrial dysfunction, autophagy and defective calcium handling in AF$700,363
R01 · FY2025 · HL · contact PI
Targeting NOX4-dependent mitochondrial dysfunction, autophagy and defective calcium handling in AF$686,356
R01 · FY2024 · HL · contact PI
Targeting NOX4-dependent mitochondrial dysfunction, autophagy and defective calcium handling in AF$700,363
R01 · FY2023 · HL · contact PI
Endothelium-driven signaling network in the development of pulmonary hypertension$521,533
R01 · FY2023 · HL · contact PI
Netrin-1 and Netrin-1 Preconditioned EPCs in Vascular Protection$458,648
R01 · FY2023 · HL · contact PI
Targeting NOX4-dependent mitochondrial dysfunction, autophagy and defective calcium handling in AF$714,363
R01 · FY2022 · HL · contact PI
Endothelium-driven signaling network in the development of pulmonary hypertension$521,533
R01 · FY2022 · HL · contact PI
Netrin-1 and Netrin-1 Preconditioned EPCs in Vascular Protection$458,648
R01 · FY2022 · HL · contact PI
Phenotypes and mechanisms of pulmonary hypertension-driven cognitive impairment and Alzheimer's disease$389,771
R01 · FY2022 · HL · contact PI
Molecular mechanisms of sex difference in COVID-19 enabling novel therapeutics$155,866
R01 · FY2022 · HL · contact PI
Endothelium-driven signaling network in the development of pulmonary hypertension$521,357
R01 · FY2021 · HL · contact PI
Netrin-1 and Netrin-1 Preconditioned EPCs in Vascular Protection$458,648
R01 · FY2021 · HL · contact PI
Endothelium-driven signaling network in the development of pulmonary hypertension$534,943
R01 · FY2020 · HL · contact PI
Netrin-1 and Netrin-1 Preconditioned EPCs in Vascular Protection$458,648
R01 · FY2020 · HL · contact PI
NOXs, eNOS Uncoupling and Diabetic Atherogenesis$510,594
R01 · FY2019 · HL · contact PI
Angiotensin II Uncoupling of Enos in Hypertension$356,789
R01 · FY2019 · HL · contact PI
NOXs, eNOS Uncoupling and Diabetic Atherogenesis$510,594
R01 · FY2018 · HL · contact PI
Angiotensin II Uncoupling of Enos in Hypertension$356,789
R01 · FY2018 · HL · contact PI
NOXs, eNOS Uncoupling and Diabetic Atherogenesis$541,394
R01 · FY2017 · HL · contact PI
Endothelium-Myocardium Interaction in Netrin-1 Induced Cardioprotection$507,706
R01 · FY2017 · HL · contact PI
Angiotensin II Uncoupling of Enos in Hypertension$356,789
R01 · FY2017 · HL · contact PI
NOXs, eNOS Uncoupling and Diabetic Atherogenesis$541,394
R01 · FY2016 · HL · contact PI
Endothelium-Myocardium Interaction in Netrin-1 Induced Cardioprotection$507,706
R01 · FY2016 · HL · contact PI
Angiotensin II Uncoupling of Enos in Hypertension$356,789
R01 · FY2016 · HL · contact PI
NOXs, eNOS Uncoupling and Diabetic Atherogenesis$510,594
R01 · FY2015 · HL · contact PI
Endothelium-Myocardium Interaction in Netrin-1 Induced Cardioprotection$500,090
R01 · FY2015 · HL · contact PI
Role of Vascular Oxidative Stress in Obesity$466,926
R01 · FY2015 · HL · contact PI
Endothelium-Myocardium Interaction in Netrin-1 Induced Cardioprotection$497,551
R01 · FY2014 · HL · contact PI
Role of Vascular Oxidative Stress in Obesity$468,598
R01 · FY2014 · HL · contact PI
Angiotensin II Uncoupling of eNOS in Hypertension$377,300
R01 · FY2014 · HL · contact PI
Mitochondrial pathways in NO induced cardioprotection$652,306
R01 · FY2013 · HL
Endothelium-Myocardium Interaction in Netrin-1 Induced Cardioprotection$483,335
R01 · FY2013 · HL · contact PI
Role of Vascular Oxidative Stress in Obesity$459,026
R01 · FY2013 · HL · contact PI
NOXs, eNOS Uncoupling and Diabetic Atherogenesis$447,441
R01 · FY2013 · HL · contact PI
Angiotensin II Uncoupling of eNOS in Hypertension$366,520
R01 · FY2013 · HL · contact PI
Mitochondrial pathways in NO induced cardioprotection$685,195
R01 · FY2012 · HL
Role of Vascular Oxidative Stress in Obesity$499,562
R01 · FY2012 · HL · contact PI
NOXs, eNOS Uncoupling and Diabetic Atherogenesis$470,002
R01 · FY2012 · HL · contact PI
Angiotensin II Uncoupling of eNOS in Hypertension$385,000
R01 · FY2012 · HL · contact PI
Mitochondrial pathways in NO induced cardioprotection$685,195
R01 · FY2011 · HL
NOXs, eNOS Uncoupling and Diabetic Atherogenesis$470,002
R01 · FY2011 · HL · contact PI
Angiotensin II Uncoupling of eNOS in Hypertension$385,000
R01 · FY2011 · HL · contact PI
Mitochondrial pathways in NO induced cardioprotection$615,116
R01 · FY2010 · HL
NOXs, eNOS Uncoupling and Diabetic Atherogenesis$460,920
R01 · FY2010 · HL · contact PI
Angiotensin II uncoupling of eNOS in hypertension$365,049
R01 · FY2009 · HL · contact PI
Angiotensin II uncoupling of eNOS in hypertension$365,049
R01 · FY2008 · HL · contact PI
Angiotensin II uncoupling of eNOS in hypertension$365,049
R01 · FY2007 · HL · contact PI
Angiotensin II uncoupling of eNOS in hypertension$374,732
R01 · FY2006 · HL · contact PI
Endocardial dysfunction in humans with AF$99,272
R21 · FY2006 · HL · contact PI
Endocardial dysfunction in humans with AF$50,621
R21 · FY2006 · HL · contact PI
Angiotensin II uncoupling of eNOS in hypertension$381,250
R01 · FY2005 · HL
Endocardial dysfunction in humans with AF$152,500
R21 · FY2005 · HL